Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc.（NBIX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · NBIX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
26
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Neurocrine Biosciences, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
NBIX 季度内部人买卖趋势
NBIX 内幕交易卖出 · NBIX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · NBIX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NBIX 高管卖出股份 · NBIX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 2, 2026 | Cooke Julie Chief Human Resources Officer | Option | 24,965 | $2.03M⚡ | Form 4 |
| Jun 2, 2026 | Cooke Julie Chief Human Resources Officer | Sale | 14,214 | $2.20M⚡ | Form 4 |
| Jun 2, 2026 | Cooke Julie Chief Human Resources Officer | Sale | 5,466 | $850K | Form 4 |
| Jun 2, 2026 | Cooke Julie Chief Human Resources Officer | Sale | 4,216 | $661K | Form 4 |
| Jun 2, 2026 | Cooke Julie Chief Human Resources Officer | Sale | 9,521 | $1.50M⚡ | Form 4 |
| Jun 2, 2026 | Cooke Julie Chief Human Resources Officer | Sale | 3,520 | $558K | Form 4 |
| Jun 2, 2026 | Keswani Sanjay Chandru Chief Medical Officer | Option | 3,212 | — | Form 4 |
| Jun 2, 2026 | Keswani Sanjay Chandru Chief Medical Officer | Other | 1,733 | $268K | Form 4 |
| Jun 1, 2026 | Onyia Jude Chief Scientific Officer | Option | 11,000 | $932K | Form 4 |
| Jun 1, 2026 | Onyia Jude Chief Scientific Officer | Sale | 11,000 | $1.76M⚡ | Form 4 |
| May 29, 2026 | Delaet Ingrid Chief Regulatory Officer | Option | 2,261 | $179K | Form 4 |
| May 29, 2026 | Delaet Ingrid Chief Regulatory Officer | Sale | 2,261 | $354K | Form 4 |
| May 27, 2026 | Onyia Jude Chief Scientific Officer | Option | 11,000 | $932K | Form 4 |
| May 27, 2026 | Onyia Jude Chief Scientific Officer | Sale | 11,000 | $1.71M⚡ | Form 4 |
| May 26, 2026 | Boyer David W. Chief Corp. Affairs Officer | Sale | 3,888 | $609K | Form 4 |
| May 21, 2026 | SHERWIN STEPHEN A Director | Option | 3,318 | — | Form 4 |
| May 21, 2026 | Sharp Shalini Director | Option | 1,659 | — | Form 4 |
| May 21, 2026 | RASTETTER WILLIAM H Director | Option | 3,318 | — | Form 4 |
| May 21, 2026 | POPS RICHARD F Director | Option | 3,318 | — | Form 4 |
| May 21, 2026 | POON CHRISTINE A Director | Option | 3,318 | — | Form 4 |
| May 21, 2026 | Norwalk Leslie V Director | Option | 1,659 | — | Form 4 |
| May 21, 2026 | MORROW GEORGE J Director | Option | 3,318 | — | Form 4 |
| May 21, 2026 | Mercier Johanna Director | Option | 3,318 | — | Form 4 |
| May 21, 2026 | LYONS GARY A Director | Option | 1,659 | — | Form 4 |
| May 19, 2026 | GORMAN KEVIN CHARLES Director | Option | 205,088 | $8.87M⚡ | Form 4 |
Cooke Julie
Chief Human Resources Officer
日期
Jun 2
股数
24,965
均价
$81.49
总金额
$2.03M ⚡
Cooke Julie
Chief Human Resources Officer
日期
Jun 2
股数
14,214
均价
$154.83
总金额
$2.20M ⚡
Cooke Julie
Chief Human Resources Officer
日期
Jun 2
股数
9,521
均价
$157.62
总金额
$1.50M ⚡
Keswani Sanjay Chandru
Chief Medical Officer
日期
Jun 2
股数
1,733
均价
$154.84
总金额
$268K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NBIX 内幕交易
NBIX 内幕交易
Neurocrine Biosciences, Inc.（NBIX）内幕交易数据来源于公司内部人（包括Boyer David W. (Chief Corp. Affairs Officer), ABERNETHY MATT (CFO), Gano Kyle (CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。NBIX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Neurocrine Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
NBIX 内幕交易 · 5个问题Neurocrine Biosciences, Inc.（NBIX）的内部人包括高管和董事，如Boyer David W. (Chief Corp. Affairs Officer), ABERNETHY MATT (CFO), Gano Kyle (CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026